Liber Pharmaceuticals

Liber Pharmaceuticals is an Australian specialty pharmaceutical company focused on the development and commercialization of medical-grade nicotine delivery systems for smoking cessation. The company's flagship product, Liber, is a pressurized metered-dose inhaler (pMDI) that delivers nicotine aerosol to the lungs, providing a rapid-acting alternative to traditional cigarettes. Designed to meet stringent pharmaceutical standards, Liber is available as a prescription-only medicine in Australia and is intended to help smokers manage withdrawal symptoms and transition away from combustible tobacco. The company focuses on providing a regulated, safer alternative to unregulated vaping products and traditional nicotine replacement therapies.